Method for treating central nervous system disorders using dopamine D3 partial agonists
Grant
US12582648B2
Kind: B2
Mar 24, 2026
Assignee
BIOPROJET PHARMA
Inventors
Jeanne-Marie Lecomte, Jean Charles Schwartz, Isabelle Berrebi-Bertrand, Stéphane Krief, Xavier Ligneau, Isabelle Lecomte
Abstract
Disclosed is a method of using D3 partial agonists for treating or inhibiting the restless leg syndrome, binge eating, essential tremor and neurodegenerative diseases, in particular D3 partial agonists/D2 antagonists.
CPC Classifications
A61K 31/495
A61P 25/16
A61P 25/28
A61P 25/00
Filing Date
2021-05-04
Application No.
17922767
Claims
4